Gemcitabine, Docetaxel a Viable Alternative to BCG in Bladder Cancer
Less high-grade disease recurrence and lower treatment discontinuation seen with gemcitabine and docetaxel versus bacillus Calmette-Guérin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.